Acute Heart Failure Therapeutics Market
According to Intent Market Research, the Acute Heart Failure Therapeutics Market is expected to grow from USD 5.9 billion in 2023 at a CAGR of 6.7% to touch USD 9.2 billion by 2030. The Acute Heart Failure Therapeutics Market is dominated by key players such as, AstraZeneca PLC, Novartis International AG, Johnson & Johnson, Eli Lilly and Company, and Bristol-Myers Squibb Company